Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Journal of Medical Economics|April 3, 2012
Healthcare resource use in advanced prostate cancer patients treated with docetaxelManeesha Mehra, Ying Wu, Ravinder DhawanJournal of Glaucoma|November 16, 2006
Considerations in developing model-based economic evaluations of glaucoma treatmentRikard Althin, Daniel T Grima, Ravinder Dhawan, et al.BJU International|February 14, 2006
Medical visits among adults with symptoms commonly associated with an overactive bladderSunny H Kim, Mark Boye, Samir K Bhattacharyya, et al.European Journal of Haematology|September 18, 2010
The cost-effectiveness of bortezomib in relapsed/refractory multiple myeloma: Swedish perspectiveJohn Hornberger, Joseph Rickert, Ravinder Dhawan, et al.Pharmacoeconomics|May 18, 2005
The health-related quality of life and economic burden of constipationCheryl Dennison, Manishi Prasad, Andrew Lloyd, et al.Health and Quality of Life Outcomes|November 18, 2003
A new measure of patient satisfaction with ocular hypotensive medications: the Treatment Satisfaction Survey for Intraocular Pressure (TSS-IOP)Mark J Atkinson, William C Stewart, Joel M Fain, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2006
Descriptive and prognostic value of patient-reported outcomes: the bortezomib experience in relapsed and refractory multiple myelomaDominique Dubois, Ravinder Dhawan, Helgi van de Velde, et al.Clinical Genitourinary Cancer|July 22, 2017
Real-world Characteristics and Outcomes of Patients With Metastatic Castration-resistant Prostate Cancer Receiving Chemotherapy Versus Androgen Receptor-targeted Therapy After Failure of First-line Androgen Receptor-targeted Therapy in the Community SettingWilliam K Oh, Raymond Miao, Francis Vekeman, et al.Medical Oncology (Northwood, London, England)|August 11, 2017
Patient characteristics and overall survival in patients with post-docetaxel metastatic castration-resistant prostate cancer in the community settingWilliam K Oh, Raymond Miao, Francis Vekeman, et al.Journal of Clinical Epidemiology|June 19, 2007
Patient-reported outcomes helped predict survival in multiple myeloma using partial least squares analysisMuriel Viala, Asha L Bhakar, Christine de la Loge, et al.Pageof 2